Home › Neuroendocrine Carcinoma › Michigan
Neuroendocrine Carcinoma clinical trials in Michigan
3 studies for Neuroendocrine Carcinoma are looking for participants at sites in Michigan.
Cities in Michigan
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
- Crinetics Study Site, Detroit
- Crinetics Study Site, Grand Rapids
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 31, 2026 · NCT07129252A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
- START Midwest, Grand Rapids
- The Cancer and Hematology Centers, Grand Rapids
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Jul 9, 2026 · NCT07174583A Study of MT-4561 in Patients With Various Advanced Solid Tumors
- START Midwest, Grand Rapids
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Dec 11, 2025 · NCT06943521From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.